Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-13 12:50 pm Unchanged |
2024-12-31 | 13G | Spruce Biosciences, Inc. SPRB |
Rosalind Advisors, Inc. | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2025-01-10 11:05 am Sale |
2025-01-07 | 13D | Spruce Biosciences, Inc. SPRB |
RiverVest Venture Fund III, L.P. | 1,759,521 4.200% |
-1,767,760 (-50.12%) |
Filing History |
| 2024-11-14 5:45 pm Sale |
2024-09-30 | 13G | Spruce Biosciences, Inc. SPRB |
5AM Opportunities II L.P. | 1,773,000 4.100% |
-2,364,000 (-57.14%) |
Filing History |
| 2024-11-14 4:39 pm Sale |
2024-09-30 | 13G | Spruce Biosciences, Inc. SPRB |
Armistice Capital, LLC | 2,169,245 4.990% |
-60,755 (-2.72%) |
Filing History |
| 2024-11-12 4:10 pm Purchase |
2024-09-30 | 13G | Spruce Biosciences, Inc. SPRB |
Radoff Bradley Louis | 3,975,000 9.600% |
1,150,000 (+40.71%) |
Filing History |
| 2024-10-23 2:26 pm Sale |
2024-09-30 | 13G | Spruce Biosciences, Inc. SPRB |
Rosalind Advisors, Inc. | 0 0.000% |
-1,508,419 (Position Closed) |
Filing History |
| 2024-04-25 6:52 pm Sale |
2024-03-31 | 13G | Spruce Biosciences, Inc. SPRB |
Rosalind Advisors, Inc. | 1,508,419 3.670% |
-813,581 (-35.04%) |
Filing History |
| 2024-03-28 9:15 pm Sale |
2024-03-26 | 13D | Spruce Biosciences, Inc. SPRB |
Novo Holdings A/S | 1,656,000 3.900% |
-1,100,000 (-39.91%) |
Filing History |
| 2024-03-28 12:42 pm Purchase |
2024-03-22 | 13G | Spruce Biosciences, Inc. SPRB |
Radoff Bradley Louis | 2,825,000 6.900% |
2,825,000 (New Position) |
Filing History |
| 2024-03-25 9:48 pm Sale |
2024-03-21 | 13D | Spruce Biosciences, Inc. SPRB |
Novo Holdings A/S | 2,756,000 6.400% |
-1,915,021 (-41.00%) |
Filing History |
| 2024-03-20 9:31 pm Sale |
2024-03-18 | 13D | Spruce Biosciences, Inc. SPRB |
Novo Holdings A/S | 4,671,021 10.900% |
-1,794,999 (-27.76%) |
Filing History |
| 2024-03-18 9:16 pm Sale |
2024-03-14 | 13D | Spruce Biosciences, Inc. SPRB |
Novo Holdings A/S | 6,466,020 15.100% |
-1,912,316 (-22.82%) |
Filing History |
| 2024-03-07 4:07 pm Unchanged |
2024-03-07 | 13D | Spruce Biosciences, Inc. SPRB |
HealthCap VIII L.P. | 3,685,621 8.900% |
0 (Unchanged) |
Filing History |
| 2024-02-14 4:57 pm Sale |
2023-12-31 | 13G | Spruce Biosciences, Inc. SPRB |
Citadel Advisors LLC | 108,240 0.300% |
-1,639,151 (-93.81%) |
Filing History |
| 2024-02-14 3:54 pm Purchase |
2023-12-31 | 13G | Spruce Biosciences, Inc. SPRB |
Armistice Capital, LLC | 2,230,000 5.480% |
2,230,000 (New Position) |
Filing History |
| 2024-02-14 2:11 pm Purchase |
2023-12-31 | 13G | Spruce Biosciences, Inc. SPRB |
Rock Springs Capital Management LP | 2,609,125 6.410% |
986,436 (+60.79%) |
Filing History |
| 2024-02-06 4:15 pm Purchase |
2023-12-31 | 13G | Spruce Biosciences, Inc. SPRB |
Aisling Capital V, LP | 1,205,511 3.000% |
1,205,511 (New Position) |
Filing History |
| 2024-01-30 11:06 am Purchase |
2024-01-24 | 13G | Spruce Biosciences, Inc. SPRB |
Rosalind Advisors, Inc. | 2,322,000 5.670% |
2,322,000 (New Position) |
Filing History |
| 2023-05-30 4:48 pm Purchase |
2023-02-16 | 13D | Spruce Biosciences, Inc. SPRB |
RiverVest Venture Fund III, L.P. | 3,527,281 8.600% |
1,379,000 (+64.19%) |
Filing History |
| 2023-02-27 4:00 pm Purchase |
2023-02-17 | 13G | Spruce Biosciences, Inc. SPRB |
5AM Opportunities II L.P. | 4,137,000 9.970% |
4,137,000 (New Position) |
Filing History |